Novo Nordisk Supports Consolidation of Wegovy, Ozempic Stomach Paralysis Lawsuits in MDL
Dozens of lawsuits have been filed by users of Ozempic, Wegovy and other GLP-1 drugs involving stomach paralsysis or gastroparesis. However, Eli Lilly maintains that Mounjaro lawsuits should be excluded from the MDL.